Fresenius Medical Care (FMS) said Tuesday that it targets to reach mid-teens percentage in operating income margins by 2030 through its FME Reignite strategy.
The company said it has estimated 1.05 billion euros ($1.21 billion) in sustainable savings by the end of 2027 from its extended FME25 program, which it expects to help support its targeted operating income margins.
Fresenius' chief financial officer, Martin Fischer, said the company plans to allocate 800 million euros to 1 billion euros for capital expenditures annually for 2025 to 2030 to invest in its core business.
Additionally, Fresenius said it is starting a new share buyback program this year, with initial share repurchases of 1 billion euros over two years.
Shares of Fresenius were down more than 3% in recent premarket activity Tuesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。